Winston Medical Supply Co., Ltd. (TPEX:6817)

Market Cap	1.47B
Revenue (ttm)	724.35M
Net Income (ttm)	134.23M
Shares Out	18.42M
EPS (ttm)	7.26
PE Ratio	10.96
Forward PE	n/a
Dividend	7.00 (8.83%)
Ex-Dividend Date	Jun 13, 2025

Volume	17,160
Average Volume	50,690
Open	79.50
Previous Close	79.60
Day's Range	78.30 - 83.50
52-Week Range	76.60 - 117.50
Beta	0.03
RSI	29.44
Earnings Date	Mar 26, 2026

About Winston Medical Supply

Winston Medical Supply Co.,Ltd. develops, manufactures, and distributes pharmaceuticals, nutrition supplements, and cosmeceutical products in Taiwan and internationally. The company offers sterile ophthalmic preparations comprising gels, suspensions, solutions, and emulsions; hormone preparations, which primarily cover birth control and oral suspension for cancer related cachexia; external use preparations comprising ointments; and other oral preparations that are in oral dosage forms, such as powders, troches, tablets, film coated tablets, che...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1974
• Employees: 180
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6817

Financial Performance

In 2024, Winston Medical Supply's revenue was 695.08 million, a decrease of -1.97% compared to the previous year's 709.07 million. Earnings were 131.59 million, a decrease of -17.11%.